BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19874824)

  • 1. Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility.
    Hakomori SI
    FEBS Lett; 2010 May; 584(9):1901-6. PubMed ID: 19874824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains.
    Regina Todeschini A; Hakomori SI
    Biochim Biophys Acta; 2008 Mar; 1780(3):421-33. PubMed ID: 17991443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse.
    Todeschini AR; Dos Santos JN; Handa K; Hakomori SI
    J Biol Chem; 2007 Mar; 282(11):8123-33. PubMed ID: 17215249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway.
    Todeschini AR; Dos Santos JN; Handa K; Hakomori SI
    Proc Natl Acad Sci U S A; 2008 Feb; 105(6):1925-30. PubMed ID: 18272501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
    Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
    Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GM3 and cancer.
    Hakomori SI; Handa K
    Glycoconj J; 2015 Feb; 32(1-2):1-8. PubMed ID: 25613425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor.
    Toledo MS; Suzuki E; Handa K; Hakomori S
    J Biol Chem; 2005 Apr; 280(16):16227-34. PubMed ID: 15710618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM2/GM3 controls the organizational status of CD82/Met microdomains: further studies in GM2/GM3 complexation.
    Santos RCM; Lucena DMS; Loponte HFBR; Alisson-Silva F; Dias WB; Lins RD; Todeschini AR
    Glycoconj J; 2022 Oct; 39(5):653-661. PubMed ID: 35536494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9.
    Mitsuzuka K; Handa K; Satoh M; Arai Y; Hakomori S
    J Biol Chem; 2005 Oct; 280(42):35545-53. PubMed ID: 16103120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and function of glycosphingolipids and sphingolipids: recollections and future trends.
    Hakomori SI
    Biochim Biophys Acta; 2008 Mar; 1780(3):325-46. PubMed ID: 17976918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines.
    Guan F; Handa K; Hakomori SI
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7461-6. PubMed ID: 19380734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexes of tetraspanins with integrins: more than meets the eye.
    Berditchevski F
    J Cell Sci; 2001 Dec; 114(Pt 23):4143-51. PubMed ID: 11739647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells.
    Ono M; Handa K; Withers DA; Hakomori S
    Biochem Biophys Res Commun; 2000 Dec; 279(3):744-50. PubMed ID: 11162423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane microdomains in immunity: glycosphingolipid-enriched domain-mediated innate immune responses.
    Iwabuchi K; Nakayama H; Masuda H; Kina K; Ogawa H; Takamori K
    Biofactors; 2012; 38(4):275-83. PubMed ID: 22488955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of "glycosphingolipid signaling domain" from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling.
    Iwabuchi K; Handa K; Hakomori S
    J Biol Chem; 1998 Dec; 273(50):33766-73. PubMed ID: 9837965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [GEM (glycosphingolipid enriched microdomain) and cancer].
    Ono M
    Tanpakushitsu Kakusan Koso; 2002 Mar; 47(4 Suppl):365-70. PubMed ID: 11915328
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of the palmitoylation-deficient CD151 weakens the association of alpha 3 beta 1 integrin with the tetraspanin-enriched microdomains and affects integrin-dependent signaling.
    Berditchevski F; Odintsova E; Sawada S; Gilbert E
    J Biol Chem; 2002 Oct; 277(40):36991-7000. PubMed ID: 12110679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traveling for the glycosphingolipid path.
    Hakomori S
    Glycoconj J; 2000; 17(7-9):627-47. PubMed ID: 11421354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional roles of glycosphingolipids in signal transduction via lipid rafts.
    Kasahara K; Sanai Y
    Glycoconj J; 2000; 17(3 -4):153-62. PubMed ID: 11201786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosphingolipids govern gene expression.
    Inokuchi J; Kabayama K; Uemura S; Igarashi Y
    Glycoconj J; 2004; 20(3):169-78. PubMed ID: 15090730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.